Glooko Inks Partnership Deal With Companion Medical To Integrate Insulin Pen Data
Glooko entered a partnership to integrate Companion Medical's InPen insulin data into Glooko's diabetes management systems.
You may also be interested in...
ADA 2019: Real-World Study Shows Abbott's FreeStyle Libre CGM Reduced HbA1c Levels In Type 2 Diabetics
At this year's annual American Diabetes Association (ADA) conference, Abbott presented real-world data from its FreeStyle Libre CGM suggesting it reduces HbA1c in type 2 diabetics. Look for more ADA coverage this week.
T1D Exchange, a nonprofit research group, will use Glooko’s diabetes data management platform to leverage diabetes device data from thousands of type 1 diabetics and link it with patients’ health records data at participating medical centers. Thanks to the agreement, researchers will gain access to data that can be used to improve patient care and outcomes.
In this edition of the Device Week podcast, Medtech Insight managing editor Marion Webb discusses LifeSignals’ plans for a vital-sign monitoring patch that could help remotely monitor patients during the pandemic. Deputy editor Reed Miller highlights some important device trials presented at the American College of Cardiology online conference.